MYO6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.086800E-01
Normal-vs-Stage2
4.679800E-01
Normal-vs-Stage3
3.830200E-01
Normal-vs-Stage4
1.509550E-01
Stage1-vs-Stage2
9.354600E-01
Stage1-vs-Stage3
1.777600E-01
Stage1-vs-Stage4
1.603590E-01
Stage2-vs-Stage3
7.004300E-02
Stage2-vs-Stage4
1.834180E-02
Stage3-vs-Stage4
3.575600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.485000E-01
Normal-vs-AfricanAmerican
3.755000E-01
Normal-vs-Asian
4.465400E-01
Caucasian-vs-AfricanAmerican
1.590640E-01
Caucasian-vs-Asian
3.156600E-01
AfricanAmerican-vs-Asian
7.103600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.167400E-01
Normal-vs-Female
4.999800E-01
Male-vs-Female
4.829000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.135400E-01
Normal-vs-Age(41-60Yrs)
3.544200E-01
Normal-vs-Age(61-80Yrs)
6.114000E-01
Normal-vs-Age(81-100Yrs)
5.984000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.198200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.958000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.088400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.847600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.840600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.780200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.297800E-01
Normal-vs-Daily Drinker
8.726600E-01
Normal-vs-Weekly Drinker
9.447800E-01
Normal-vs-Occasional Drinker
3.723200E-01
Normal-vs-Social Drinker
4.921800E-01
Non Drinker-vs-Daily Drinker
8.330300E-02
Non Drinker-vs-Weekly Drinker
2.801000E-01
Non Drinker-vs-Occasional Drinker
5.614800E-01
Non Drinker-vs-Social Drinker
5.471200E-01
Daily Drinker-vs-Weekly Drinker
6.754600E-01
Daily Drinker-vs-Occasional Drinker
3.220100E-02
Daily Drinker-vs-Social Drinker
1.059400E-01
Weekly Drinker-vs-Occasional Drinker
1.338200E-01
Weekly Drinker-vs-Social Drinker
2.110600E-01
Occasional Drinker-vs-Social Drinker
9.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.059600E-02
Normal-vs-Grade 2
9.585000E-03
Normal-vs-Grade 3
1.426120E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.712800E-01
Grade 1-vs-Grade 3
6.962200E-02
Grade 1-vs-Grade 4
8.059600E-02
Grade 2-vs-Grade 3
1.536370E-01
Grade 2-vs-Grade 4
9.585000E-03
Grade 3-vs-Grade 4
1.426120E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.343000E-01
Normal-vs-NonDiabetic
4.945000E-01
Diabetic-vs-NonDiabetic
1.194760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.718000E-01
Normal-vs-NoPancreatitis
5.748800E-01
Pancreatitis-vs-NoPancreatitis
7.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.023600E-01
Normal-vs-N1
4.877800E-01
N0-vs-N1
8.137600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.297000E-01
Normal-vs-TP53-NonMutant
4.614000E-01
TP53-Mutant-vs-TP53-NonMutant
1.569620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
